List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 20 studies with search of: "Endotoxemia"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Study of Renal Blood Flow During Human Endotoxemia
Conditions: Healthy;   Type 2 Diabetes;   Endotoxemia
Intervention: Drug: Escherichia Coli Endotoxin
2 Completed Blockade of Vascular Potassium Channels During Human Endotoxemia
Condition: Endotoxemia
Interventions: Drug: endotoxin;   Drug: Potassium channel blockers: TEA, Quinin, Tolbutamide;   Drug: L-NMMA
3 Completed Effect of Selective iNOS Inhibition During Human Endotoxemia
Condition: Endotoxemia
Interventions: Drug: Aminoguanidine;   Drug: endotoxin
4 Completed Cerebral Blood Flow and Metabolism During Hypoxia and Endotoxemia
Conditions: Hypoxia;   Endotoxemia;   Healthy
Intervention: Procedure: Endotoxin infusion, Normobaric hypoxia
5 Recruiting In Vivo Effects of C1-Esterase Inhibitor on the Innate Immune Response During Human Endotoxemia
Conditions: Endotoxemia;   Inflammation;   Multi Organ Dysfunction Syndrome
Interventions: Drug: C1-esterase inhibitor;   Drug: Endotoxin administration
6 Completed Study of Gene Activity in Fat and Muscle in Diabetics and Healthy Controls
Conditions: Healthy;   Type 2 Diabetes;   Endotoxemia
Intervention: Drug: Escherichia Coli Endotoxin
7 Active, not recruiting Low-Dose Endotoxemia and the Acute Phase Response
Conditions: Endotoxemia;   Sepsis
Intervention: Drug: E. Coli endotoxin
8 Active, not recruiting Anti-Inflammatory Effects of GTS-21 After LPS
Conditions: Endotoxemia;   Sepsis;   Vagal Activity
Interventions: Drug: GTS-21, [3-(2,4-dimethoxybenzylidene)-anabaseine dihydrochloride];   Drug: Placebo;   Drug: Lipopolysaccharide E. Coli 113:H 10:K negative
9 Recruiting A Possible Therapeutic Role for Adenosine During Inflammation
Condition: Endotoxemia
Interventions: Genetic: AMPD1 polymorphism;   Drug: Caffeine infusion;   Drug: placebo
10 Completed Pathophysiology and Clinical Relevance of Endotoxin Tolerance in Humans
Condition: Endotoxemia
Intervention: Drug: repeated injections of endotoxin during 5 days
11 Recruiting Type 2 Diabetes and the Effect of Probiotics
Conditions: Type 2 Diabetes;   Healthy;   Endotoxemia
Intervention: Drug: Lactobacillus acidophilus NCFM
12 Completed Ethnic Differences in the Inflammatory Response in Systemic Inflammation
Condition: Endotoxemia
Intervention: Drug: LPS
13 Completed Anti-Inflammatory Effect of Statins in the Human Endotoxin Model
Condition: Endotoxemia
Interventions: Drug: LPS 2ng/kg intravenous bolus;   Drug: Simvastatin 80mg; administered daily p.o. over 5 days;   Drug: Rosuvastatin 40mg; administered daily p.o. over 5 days
14 Recruiting The Effects of Epinephrine in Endotoxemia in Normal Volunteers
Condition: Immune System
Interventions: Biological: Endotoxin, Lipopolysaccharide, LPS;   Biological: Endotoxin, Lipopolysaccharide, LPS /Epinephrine
15 Completed Lipid Infusion in Dialysis Patients With Endotoxemia
Conditions: Fatigue;   Hemodialysis;   ESRD
Interventions: Drug: Lipidose;   Drug: Placebo
16 Completed The Effect of Glutamine on Systemic Inflammation During Human Experimental Endotoxemia
Conditions: Sepsis;   Systemic Inflammation
Intervention: Dietary Supplement: alanine-glutamine infusion
17 Recruiting Role of Nitric Oxide in Cirrhosis: Relationship With Systemic Hemodynamics, Renal Function, Vasoactive Systems and Endotoxemia
Conditions: Cirrhosis;   Liver Cirrhosis
Intervention: Drug: N-monomethyl-L-arginine
18 Recruiting Effects of a Western-Type Diet on Colorectal Inflammation
Condition: Colorectal Inflammation
Interventions: Dietary Supplement: Western style diet (high fat and low in calcium);   Dietary Supplement: Prudent-style diet (low fat and high in calcium)
19 Terminated CTI-01 (Ethyl Pyruvate) Safety and Complication Prevention in Cardiac Surgery Patients on Cardiopulmonary Bypass (CPB)
Conditions: Coronary Disease;   Heart Valve Diseases
Intervention: Drug: CTI-01 (ethyl pyruvate)
20 Completed A Safety and Efficacy Study of Intravenous E5564 in Patients With Severe Sepsis
Conditions: Sepsis;   Shock, Septic;   Sepsis Syndrome;   Septicemia;   Infection
Intervention: Drug: E5564

Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services